YPSOMED HLDG SF 14,15/ CH0019396990 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 5.86 bill.EUR | - | - |
Fundamentals
FY 2024 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 5.74 CHF | 50.26% |
EPS Diluted: | - CHF | 50.26% |
Revenues per Share: | 40.18 CHF | 10.25% |
Book Value per Share: | 45.26 CHF | 9.85% |
Cash Flow per Share: | 11.96 CHF | 26.01% |
Dividend per Share: | 2.00 CHF | 53.85% |
Total | in mill. | |
Revenues: | 548.46 CHF | 10.25% |
Net Income: | 78.37 CHF | 52.83% |
Operating Cash Flow: | 163.22 CHF | - |
Cash and Cash Equivalents: | 74.02 CHF | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 71.60 | 62.80 |
P/S Ratio: | 10.23 | 8.97 |
P/BV ratio: | 9.08 | 7.97 |
P/CF Ratio: | 34.37 | 30.15 |
PEG: | 1.42 | 1.25 |
Earnings Yield: | 1.40% | 1.59% |
Dividend Yield: | 0.49% | 0.55% |
Market Capitalization | ||
Market Capitalization: | 5.86 bill. EUR | 5.14 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 2.45 mill. EUR | 2.15 mill. EUR |
Shares Outstanding: | 13.65 mill. |
Profitability
Gross Profit Margin: | 34.47% |
EBIT Margin: | 15.72% |
Net Profit Margin: | 14.29% |
Return on Equity: | 12.69% |
Return on Assets: | 7.12% |
Financial Strength
Liquidity I / Cash Ratio: | 16.81% |
Liquidity II / Quick Ratio: | 45.90% |
Liquidity III / Current Ratio: | 76.77% |
Debt / Equity Ratio: | 78.30% |
Dynam. Debt / Equity Ratio: | 296.32% |
Efficiency
Employees: | 2,389 |
Personal Expenses / Employee: | - CHF |
Revenues / Employee: | 229,575.97 CHF |
Net Income / Employee: | 32,802.85 CHF |
Total Assets / Employee: | 461,027.63 CHF |
* Fiscal Year End: | 31/03/2024 |
Accounting Standard: | Swiss GAAP FER |
Currency: | CHF |